Europe FMD Vaccine Market

Published Jun 01, 2026

Length 350 Pages

SKU # DAABD21414212

Description

The Europe FMD vaccine market is expected to reach USD 1,338.90 million by 2033 from USD 790.24 million in 2025, growing with a CAGR of 7.0% in the forecast period of 2026 to 2033.

Market Segmentation:
By Vaccine Type (Conventional Vaccines, Next-Generation / Advanced Vaccines, Others), By Type (Multivalent Vaccines, Monovalent Vaccines), By Vaccination Route (Intramuscular, Subcutaneous, Others), By Animal Type (Bovine, Porcine, Ovine, Caprine, others), By Formulation Type (Liquid Vaccines, Lyophilized (Freeze-Dried) Vaccines, Others), By Application (Routine Prophylactic Vaccination, Emergency Vaccination (Outbreak Control), Others), By End User (Commercial Livestock Farms, Veterinary Hospitals, Veterinary Care Centers, Vaccination Centers, Others), By Distribution Channel (Direct Sales (Government Procurement & Tender Supply), Retail Sales, Others), By Country (Turkey, Russia, Germany, France, U.K., Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Norway, Denmark, Finland, Rest of Europe). Industry Trends and Forecast to 2033.

Overview of Europe FMD Vaccine Market Dynamics:

Drivers
• Growth in Europe livestock population
• Rising prevalence of FMD outbreaks
• Growing government vaccination programs
• Increasing awareness of animal health and biosecurity
Restraints
• Limited cold chain infrastructure
• Vaccine hesitancy and field challenges
Opportunitites
• Integration of digital veterinary surveillance systems
• Rising adoption of multivalent and high-potency vaccines
• Emerging markets with high livestock populations
Challenges
• Viral mutation and serotype variability
• Enforcement of vaccination regulations
Market Players:

The key players operating in the Europe FMD Vaccine market are:
• Zoetis (US)
• Boehringer Ingelheim (Germany)
• Wuhan Institute of Biological Products Co., Ltd. (China)
• Ceva Santé Animale (France)
• Botswana Vaccine Institute (Botswana)
• Biogénesis Bagó (Argentina)
• Indian Immunologicals Ltd. (India)
• Brilliant Bio Pharma Ltd. (India)
• CAHIC (China)
• Vetal Animal Health (India)
• Vecol S.A. (Netherlands)
• Biovet Pvt. Ltd. (India)
• Limor de Colombia (Colombia)
• MEVAC (Egypt)
• Kenya Veterinary Vaccines Production Institute (Kenya)
• National Veterinary Institute (Ethiopia)
• Jinyu Bio-Technology (China)
• Shanghai Shen Lian Biomedical Corporation (China)
• Shchelkovo Biocombinat (Russia)
• Dollvet (Turkey)
• Enimmune Corp. (US)

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of Europe Fmd Vaccine Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market Application Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Econdary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestal Analysis; 4.2 Porters Five Forces Analysis; 4.3 Epidemiology Of Foot-and-mouth Disease (Fmd); 4.3.1 Fmd Incidence Rate By Species And Region; 4.3.1.1 Incidence By Species And Morbidity Burden; 4.3.1.2 Prevalence Patterns And Regional Serotype Distribution; 4.3.2 Vaccination Coverage Rate; 4.4 Mortality And Morbidity Impact; 4.4.1 Vaccine Compliance And Program Adherence; 4.4.2 Disease Containment Success Rates; 4.5 Industry Insights; 4.5.1 Micro And Macro Economic Factors; 4.5.2 Penetration And Growth Prospect Mapping; 4.5.3 Key Pricing Strategies; 4.5.4 Interviews With Specialists; 4.5.5 Analysis And Recommendation; 4.6 Company Evaluation Quadrant; 4.7 Distribution Of Products And Projects By Phase Europe Fmd Vaccine Market; 4.8 Distribution Of Projects By Scientific Approach And Phase Europe Fmd Vaccine Market; 4.9 Distribution Of Projects By Species And Phase Europe Fmd Vaccine Market; 4.10 Europe Clinical Trial Market For Europe Fmd Vaccine Market; 4.11 Healthcare Tariffs Impact Analysis; 4.11.1 Overview; 4.11.2 Tariff Structures; 4.11.2.1 Europe Vs. Regional Tariff Structures; 4.11.2.2 United States: Usda/Aphis Tariff Policies, Animal Health Program Models; 4.11.2.2.1 European Union: Cross-border Trade Regulations, Subsidy Policies; 4.11.2.2.2 Asia-pacific: Import And Export Controls On Veterinary Vaccines; 4.11.2.2.3 Emerging Markets: Challenges In Tariff Implementation; 4.11.3 Pharmaceutical (Veterinary Biologics) Tariffs And Trade Barriers; 4.11.3.1 Import Duties On Vaccines And Biologicals; 4.11.3.2 Impact On Affordability And Access In Rural Areas; 4.11.3.3 Key Trade Agreements Affecting Animal Health Product Tariffs; 4.11.4 Impact Of Healthcare Tariffs On Providers And Farmers; 4.11.4.1 Cost Burden On Commercial Farms And Veterinarians; 4.11.4.2 Effect On Vaccine Affordability And Herd Coverage; 4.11.4.3 Tariffs And Impact On Animal Trade/Movement; 4.11.5 Trade Agreements And Animal Health Tariffs; 4.11.5.1 Wto Regulations On Veterinary Products; 4.11.5.2 Impact Of Trade Wars On Vaccine Supply Chain; 4.11.5.3 Role Of Free Trade Agreements (Ftas) In Tariff Reduction; 4.11.6 Impact Of Tariffs On Veterinary Vaccine Costs & Accessibility; 4.11.7 Importance Of Tariffs In The Animal Health Sector; 4.12 Marketed Vaccine Analysis; 4.12.1 Vaccine Brand & Generic Name / Antigenic Strain; 4.12.2 Indication; 4.12.3 Pharmacological Class Of The Vaccine; 4.12.4 Primary Indication; 4.12.5 Market Status; 4.12.6 Vaccine Type (Conventional, Next-gen, Etc.); 4.12.7 Dosage Form; 4.12.8 Dosage Availability; 4.12.9 Packaging Type; 4.12.10 Route Of Administration; 4.12.11 Dosing Frequency; 4.12.12 Vaccine Insight; 4.12.13 Overview Of Development Activities (Approvals, Safety, Efficacy, Market Exclusivity); 4.12.13.1 Forecast Market Outlook; 4.12.14 Cross Competition (By Strain/Valency); 4.12.15 Therapeutic Portfolio; 4.12.16 Current Development Scenario; 4.13 Patent Analysis; 4.13.1 Patent Quality And Strength; 4.13.2 Country Patent Landscape; 4.13.3 Ip Strategy And Management; 4.13.4 Licensing And Collaboration; 4.14 Top Entities Based On R&D Glance For Europe Fmd Vaccine Market; 4.15 Market Access; 4.15.1 10-year Market Forecast; 4.15.2 Clinical Trial Recent Updates; 4.15.3 Annual New Vaccine Approvals (Oie/Regional Authorities); 4.15.4 Leading Manufacturers And Strategic Deals; 4.15.5 Major Vaccine Uptake; 4.15.6 Current Vaccination Practices; 4.15.7 Impact Of Upcoming Technologies And Therapy; 4.16 R & D Analysis; 4.16.1 Comparative Analysis; 4.16.2 Vaccine Development Landscape; 4.16.3 In-depth Insights On Regulatory Milestones; 4.16.4 Therapeutic Assessment; 4.16.5 Asset-based Collaborations And Partnerships
5 War-driven Disruption In Veterinary Vaccine Supply Chains, Geographic Footprints, Structural Changes, And Adaptive Strategies: 5.1 Supply Chain Resilience; 5.1.1 Diversification Of Antigen And Adjuvant Ingredient Suppliers; 5.1.2 Establishment Of Regional Veterinary Vaccine Manufacturing Hubs; 5.1.3 Strategic Stockpiling Of Emergency Vaccine Banks; 5.1.4 Development Of Alternative Cold Chain Logistics Routes; 5.1.5 Strategic Partnerships With Contract Manufacturers (Cdmos); 5.1.6 Expansion Of Vaccine Fill-finish And Packaging Capacities; 5.2 Energy & Manufacturing Operational Cost Risk; 5.2.1 Rising Energy Costs In Animal Health Production Facilities; 5.2.2 Increased Costs For Biologics Raw Materials And Components; 5.2.3 Long-term Energy Procurement Strategies For Veterinary Plants; 5.2.4 Adoption Of Energy-efficient Biopharma Manufacturing Technologies; 5.2.5 Deployment Of Advanced Automation And Continuous Manufacturing; 5.2.6 Integration Of Renewable Energy In Veterinary Vaccine Plants; 5.3 Geographic Footprint Reassessment; 5.3.1 Expansion Of Vaccine Production In Politically Stable Regions; 5.3.2 Diversification Of Europe Veterinary Vaccine Bases; 5.3.3 Relocation Of Antigen Production Facilities; 5.3.4 Expansion Of Manufacturing In Emerging Animal Health Markets; 5.3.5 Establishment Of Regional Veterinary Vaccine Distribution Hubs; 5.4 Scenario Planning & Risk Management; 5.4.1 Development Of Supply Chain Contingency Plans For Outbreaks; 5.4.2 Multi-source Procurement Strategies For Key Vaccine Ingredients; 5.4.3 Government And Animal Health Authority Collaborations; 5.4.4 Crisis-response Vaccine Deployment Networks; 5.4.5 Deployment Of Supply Chain Analytics In Vaccine Distribution; 5.5 Cash & Financial Protection; 5.5.1 Strengthening Capital Reserves For Manufacturing Expansion; 5.5.2 Diversification Of Product Portfolios And Revenue Streams; 5.5.3 Investments In Domestic Vaccine Manufacturing Infrastructure; 5.5.4 Government Incentives For Animal Health Production; 5.5.5 Long-term Procurement Agreements With Governments And Organizations; 5.6 Data Protection; 5.6.1 Data Protection Frameworks For Animal Health R&D And Manufacturing; 5.6.2 Protection Of Veterinary Clinical Trial And Field Data; 5.6.3 Secure Cloud Infrastructure For Vaccine Data Management; 5.6.4 Ai-driven Threat Detection In Research And Supply Networks; 5.6.5 Compliance With Europe Animal Health Data Regulations And Gxp Standards
6 Regulatory Framework For Fmd Vaccines: 6.1 Regulatory Approval Process For Fmd Vaccines; 6.1.1 International Norms And Standards For Fmd Vaccines; 6.1.2 Biosafety And Containment Regulations; 6.2 Geographies’ Ease Of Regulatory Approval; 6.3 Regulatory Approval Pathways For Veterinary Vaccines; 6.4 Licensing And Registration Requirements; 6.5 Post-marketing Surveillance For Veterinary Products; 6.6 Good Manufacturing Practices (Gmp) Guidelines For Animal Health
7 Market Overview: 7.1 Drivers; 7.1.1 Growth In Europe Livestock Population; 7.1.2 Rising Prevalence Of Fmd Outbreaks; 7.1.3 Growing Government Vaccination Programs; 7.1.4 Increasing Awareness Of Animal Health And Biosecurity; 7.2 Restraints; 7.2.1 Limited Cold Chain Infrastructure; 7.2.2 Vaccine Hesitancy And Field Challenges; 7.3 Opportunities; 7.3.1 Integration Of Digital Veterinary Surveillance Systems; 7.3.2 Rising Adoption Of Multivalent And High-potency Vaccines; 7.3.3 Emerging Markets With High Livestock Populations; 7.4 Challenges; 7.4.1 Viral Mutation And Serotype Variability; 7.4.2 Enforcement Of Vaccination Regulations
8 Europe Fmd Vaccine Market, By Product Type: 8.1 Overview; 8.2 Conventional Vaccines; 8.3 Next-generation / Advanced Vaccines; 8.4 Others; 8.5 Europe Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); 8.5.1 Conventional Vaccines; 8.5.2 Next-generation / Advanced Vaccines; 8.5.3 Others
9 Europe Fmd Vaccine Market, By Type: 9.1 Overview; 9.2 Inactivated (Killed) Vaccines; 9.3 Live Attenuated Vaccines; 9.4 Europe Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.4.1 Asia-pacific; 9.4.2 Europe; 9.4.3 North America; 9.4.4 South America; 9.4.5 Middle East And Africa; 9.5 Europe Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); 9.5.1 Recombinant Vector-based Vaccines; 9.5.2 Virus-like Particle (Vlp) Vaccines; 9.5.3 Subunit Vaccines; 9.5.4 Others; 9.6 Europe Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.6.1 Asia-pacific; 9.6.2 Europe; 9.6.3 North America; 9.6.4 South America; 9.6.5 Middle East And Africa; 9.7 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.7.1 Asia-pacific; 9.7.2 Europe; 9.7.3 North America; 9.7.4 South America; 9.7.5 Middle East And Africa; 9.8 Europe Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); 9.8.1 Multivalent Vaccines; 9.8.2 Monovalent Vaccines; 9.9 Europe Multivalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.9.1 Asia-pacific; 9.9.2 Europe; 9.9.3 North America; 9.9.4 South America; 9.9.5 Middle East And Africa; 9.10 Europe Monovalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 9.10.1 Asia-pacific; 9.10.2 Europe; 9.10.3 North America; 9.10.4 South America; 9.10.5 Middle East And Africa
10 Europe Fmd Vaccine Market, By Vaccination Route: 10.1 Overview; 10.2 Intramuscular; 10.3 Subcutaneous; 10.4 Others; 10.5 Europe Intramuscular In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 10.5.1 Asia-pacific; 10.5.2 Europe; 10.5.3 North America; 10.5.4 South America; 10.5.5 Middle East And Africa; 10.6 Europe Subcutaneous In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 10.6.1 Asia-pacific; 10.6.2 Europe; 10.6.3 North America; 10.6.4 South America; 10.6.5 Middle East And Africa; 10.7 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 10.7.1 Asia-pacific; 10.7.2 Europe; 10.7.3 North America; 10.7.4 South America; 10.7.5 Middle East And Africa
11 Europe Fmd Vaccine Market, By Animal Type: 11.1 Overview; 11.2 Bovine; 11.3 Porcine; 11.4 Ovine; 11.5 Caprine; 11.6 Others; 11.7 Europe Bovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.7.1 Asia-pacific; 11.7.2 Europe; 11.7.3 North America; 11.7.4 South America; 11.7.5 Middle East And Africa; 11.8 Europe Porcine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.8.1 Asia-pacific; 11.8.2 Europe; 11.8.3 North America; 11.8.4 South America; 11.8.5 Middle East And Africa; 11.9 Europe Ovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.9.1 Asia-pacific; 11.9.2 Europe; 11.9.3 North America; 11.9.4 South America; 11.9.5 Middle East And Africa; 11.10 Europe Caprine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.10.1 Asia-pacific; 11.10.2 Europe; 11.10.3 North America; 11.10.4 South America; 11.10.5 Middle East And Africa; 11.11 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 11.11.1 Asia-pacific; 11.11.2 Europe; 11.11.3 North America; 11.11.4 South America; 11.11.5 Middle East And Africa
12 Europe Fmd Vaccine Market, By Formulation Type: 12.1 Overview; 12.2 Liquid Vaccines; 12.3 Lyophilized (Freeze-dried) Vaccines; 12.4 Others; 12.5 Europe Liquid Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 12.5.1 Asia-pacific; 12.5.2 Europe; 12.5.3 North America; 12.5.4 South America; 12.5.5 Middle East And Africa; 12.6 Europe Lyophilized (Freeze-dried) Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 12.6.1 Asia-pacific; 12.6.2 Europe; 12.6.3 North America; 12.6.4 South America; 12.6.5 Middle East And Africa; 12.7 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 12.7.1 Asia-pacific; 12.7.2 Europe; 12.7.3 North America; 12.7.4 South America; 12.7.5 Middle East And Africa
13 Europe Fmd Vaccine Market, By Application: 13.1 Overview; 13.2 Routine Prophylactic Vaccination; 13.3 Emergency Vaccination (Outbreak Control); 13.4 Others; 13.5 Europe Routine Prophylactic Vaccination In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 13.5.1 Asia-pacific; 13.5.2 Europe; 13.5.3 North America; 13.5.4 South America; 13.5.5 Middle East And Africa; 13.6 Europe Emergency Vaccination (Outbreak Control) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 13.6.1 Asia-pacific; 13.6.2 Europe; 13.6.3 North America; 13.6.4 South America; 13.6.5 Middle East And Africa; 13.7 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 13.7.1 Asia-pacific; 13.7.2 Europe; 13.7.3 North America; 13.7.4 South America; 13.7.5 Middle East And Africa
14 Europe Fmd Vaccine Market, By End User: 14.1 Overview; 14.2 Commercial Livestock Farms; 14.3 Veterinary Hospitals; 14.4 Veterinary Care Centers; 14.5 Vaccination Centres; 14.6 Others; 14.7 Europe Commercial Livestock Farms In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.7.1 Asia-pacific; 14.7.2 Europe; 14.7.3 North America; 14.7.4 South America; 14.7.5 Middle East And Africa; 14.8 Europe Veterinary Hospitals In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.8.1 Asia-pacific; 14.8.2 Europe; 14.8.3 North America; 14.8.4 South America; 14.8.5 Middle East And Africa; 14.9 Europe Veterinary Care Centers In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.9.1 Asia-pacific; 14.9.2 Europe; 14.9.3 North America; 14.9.4 South America; 14.9.5 Middle East And Africa; 14.10 Europe Vaccination Centres In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.10.1 Asia-pacific; 14.10.2 Europe; 14.10.3 North America; 14.10.4 South America; 14.10.5 Middle East And Africa; 14.11 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 14.11.1 Asia-pacific; 14.11.2 Europe; 14.11.3 North America; 14.11.4 South America; 14.11.5 Middle East And Africa
15 Europe Fmd Vaccine Market, By Distribution Channel: 15.1 Overview; 15.2 Direct Sales (Government Procurement & Tender Supply); 15.3 Retail Sales; 15.4 Others; 15.5 Europe Direct Sales (Government Procurement & Tender Supply) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 15.5.1 Asia-pacific; 15.5.2 Europe; 15.5.3 North America; 15.5.4 South America; 15.5.5 Middle East And Africa; 15.6 Europe Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); 15.6.1 Hospital Pharmacy; 15.6.2 Retail Pharmacy; 15.6.3 Online Pharmacy; 15.7 Europe Retail Sales In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 15.7.1 Asia-pacific; 15.7.2 Europe; 15.7.3 North America; 15.7.4 South America; 15.7.5 Middle East And Africa; 15.8 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); 15.8.1 Asia-pacific; 15.8.2 Europe; 15.8.3 North America; 15.8.4 South America; 15.8.5 Middle East And Africa
16 Europe Fmd Vaccine Market, By Region: 16.1 Europe; 16.1.1 Turkey; 16.1.2 Russia; 16.1.3 Germany; 16.1.4 France; 16.1.5 U.K.; 16.1.6 Italy; 16.1.7 Spain; 16.1.8 Netherlands; 16.1.9 Belgium; 16.1.10 Switzerland; 16.1.11 Sweden; 16.1.12 Norway; 16.1.13 Denmark; 16.1.14 Finland; 16.1.15 Rest Of Europe
17 Europe Fmd Vaccine Market: Company Landscape: 17.1 Company Share Analysis: Global
18 Swot Analysis
19 Company Profiles: 19.1 Boehringer Ingelheim International Gmbh.; 19.1.1 Company Snapshot; 19.1.2 Company Share Analysis; 19.1.3 Product Portfolio; 19.1.4 Recent Development; 19.2 Ceva Santé Animale; 19.2.1 Company Snapshot; 19.2.2 Company Share Analysis; 19.2.3 Product Portfolio; 19.2.4 Recent Development; 19.3 China Animal Husbandry Industry Co., Ltd.; 19.3.1 Company Snapshot; 19.3.2 Revenue Analysis; 19.3.3 Company Share Analysis; 19.3.4 Product Portfolio; 19.3.5 Recent Development; 19.4 Indian Immunologicals Ltd.; 19.4.1 Company Snapshot; 19.4.2 Company Share Analysis; 19.4.3 Product Portfolio; 19.4.4 Recent Development; 19.5 Biogénesis Bagó; 19.5.1 Company Snapshot; 19.5.2 Company Share Analysis; 19.5.3 Product Portfolio; 19.5.4 Recent Development; 19.6 Biovet Private Ltd; 19.6.1 Company Snapshot; 19.6.2 Product Portfolio; 19.6.3 Recent Development; 19.7 Brilliant Bio Pharma; 19.7.1 Company Snapshot; 19.7.2 Product Portfolio; 19.7.3 Recent Development; 19.8 Dollvet; 19.8.1 Company Snapshot; 19.8.2 Product Portfolio; 19.8.3 Recent Development; 19.9 Enimmune Corp.; 19.9.1 Company Snapshot; 19.9.2 Revenue Analysis; 19.9.3 Product Portfolio; 19.9.4 Recent Development; 19.10 Jinyu Biotechnology Co., Ltd.; 19.10.1 Company Snapshot; 19.10.2 Revenue Analysis; 19.10.3 Product Portfolio; 19.10.4 Recent Development; 19.11 Kenya Veterinary Vaccines Production Institute; 19.11.1 Company Snapshot; 19.11.2 Product Portfolio; 19.11.3 Recent Development; 19.12 Limor De Colombia Sas; 19.12.1 Company Snapshot; 19.12.2 Product Portfolio; 19.12.3 Recent Development; 19.13 Mevac For Vaccines; 19.13.1 Company Snapshot; 19.13.2 Product Portfolio; 19.13.3 Recent Development; 19.14 National Veterinary Institute; 19.14.1 Company Snapshot; 19.14.2 Product Portfolio; 19.14.3 Recent Development; 19.15 Shchelkovo Biocombinat; 19.15.1 Company Snapshot; 19.15.2 Product Portfolio; 19.15.3 Recent Development; 19.16 Shanghai Shen Lian Biomedical Corporation; 19.16.1 Company Snapshot; 19.16.2 Revenue Analysis; 19.16.3 Product Portfolio; 19.16.4 Recent Development; 19.17 Vetal S.A.; 19.17.1 Company Snapshot; 19.17.2 Product Portfolio; 19.17.3 Recent Development; 19.18 Vecol; 19.18.1 Company Snapshot; 19.18.2 Product Portfolio; 19.18.3 Recent Development; 19.19 Wuhan Institute Of Biological Products Co., Ltd.; 19.19.1 Company Snapshot; 19.19.2 Product Portfolio; 19.19.3 Recent Development; 19.20 Zoetis Services Llc; 19.20.1 Company Snapshot; 19.20.2 Revenue Analysis; 19.20.3 Product Portfolio; 19.20.4 Recent Development
20 Questionnaire
21 Related Reports: list Of Tables; Table 1 Europe Fmd Vaccine Pricing Structure; Table 2 Fmd Serotype Prevalence By Region; Table 3 Economic Impact Of Fmd Outbreaks; Table 4 Manufacturer Positioning Map; Table 5 Fmd Incidence, Morbidity, And Epidemiological Rates; Table 6 Fmd Serotype Prevalence By Region; Table 7 Distribution Of Products And Projects By Phase Europe Fmd Vaccine Market; Table 8 Distribution Of Projects By Scientific Approach And Phase Europe Fmd Vaccine Market; Table 9 Distribution Of Projects By Species And Phase Europe Fmd Vaccine Market; Table 10 Europe Clinical Trial Market For Europe Fmd Vaccine Market; Table 11 Dosage Form Characteristics Of Fmd Vaccines; Table 12 Dosage Availability Of Marketed Fmd Vaccines; Table 13 Therapeutic Portfolio Diversification In Fmd Vaccines; Table 14 Europe Fmd Vaccine Market, By Vaccine Type, 2025; Table 15 Europe Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 16 Europe Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 17 Europe Conventional Vaccines In Fmd Vaccine Market, By Type, 2025; Table 18 Europe Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 19 Europe Next-generation / Advanced Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 20 Europe Conventional Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 21 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 22 Europe Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 23 Europe Multivalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 24 Europe Monovalent Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 25 Europe Fmd Vaccine Market, By Vaccination Route, 2018-2033 (Usd Thousand); Table 26 Europe Intramuscular In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 27 Europe Subcutaneous In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 28 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 29 Europe Fmd Vaccine Market, By Animal Type, 2018-2033 (Usd Thousand); Table 30 Europe Bovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 31 Europe Porcine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 32 Europe Ovine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 33 Europe Caprine In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 34 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 35 Europe Fmd Vaccine Market, By Formulation Type, 2018-2033 (Usd Thousand); Table 36 Europe Liquid Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 37 Europe Lyophilized (Freeze-dried) Vaccines In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 38 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 39 Europe Fmd Vaccine Market, By Application, 2025; Table 40 Europe Routine Prophylactic Vaccination In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 41 Europe Emergency Vaccination (Outbreak Control) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 42 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 43 Europe Fmd Vaccine Market, By End User, 2025; Table 44 Europe Commercial Livestock Farms In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 45 Europe Veterinary Hospitals In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 46 Europe Veterinary Care Centers In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 47 Europe Vaccination Centres In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 48 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 49 Europe Fmd Vaccine Market, By Distribution Channel, 2025; Table 50 Europe Direct Sales (Government Procurement & Tender Supply) In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 51 Europe Retail Sales In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand); Table 52 Europe Retail Sales In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 53 Europe Others In Fmd Vaccine Market, By Region, 2018-2033 (Usd Thousand); Table 54 Europe Fmd Vaccine Market, By Country, 2018-2033 (Usd Thousand); Table 55 Europe Fmd Vaccine Market, By Country, 2018-2033 (Usd Thousand); Table 56 Europe; Table 57 Europe Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Thousand); Table 58 Europe Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Thousand Units); Table 59 Europe Fmd Vaccine Market, By Vaccine Type, 2018-2033 (Usd Per Unit); Table 60 Europe Conventional Vaccines In Fmd Vaccine Market, By Type, 2018-2033 (Usd Thousand)
List Of Figures: Figure 1 Europe Fmd Vaccine Market: Segmentation; Figure 2 Europe Fmd Vaccine Market: Data Triangulation; Figure 3 Europe Fmd Vaccine Market: Droc Analysis; Figure 4 Europe Fmd Vaccine Market: Europe Vs Regional Analysis; Figure 5 Europe Fmd Vaccine Market: Company Research Analysis; Figure 6 Europe Fmd Vaccine Market: Interview Demographics; Figure 7 Europe Fmd Vaccine Market: Dbmr Market Position Grid; Figure 8 Europe Fmd Vaccine Market: Market Application Coverage Grid; Figure 9 Europe Fmd Vaccine Market : Vendor Share Analysis; Figure 10 Executive Summary; Figure 11 Europe Fmd Vaccine Market: Segmentation; Figure 12 Strategic Decisions; Figure 13 Rising Prevalence Of Foot-and-mouth Disease And Increasing Government-led Mass Vaccination Programs Expected To Drive The Europe Fmd Vaccine Market In The Forecast Period Of 2026 To 2033

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now